NFKB1 and prostate cancer: The suppression of NF-κB activity was also reported as major mechanism by which down-regulation of CK2 sensitizes prostate cancer cells to the antitumor effect of TRAIL; however, in this case the crucial p65 phosphorylation site was Ser536 [35].